Taylor Swift Eras Tour concert film will open in theaters same day as new ‘Exorcist’ movie
A concert film of Taylor Swift's "Eras Tour" will hit theaters on October 13, going up against the release date of horror flick "The Exorcist:...
Earnings Results: Dollar General’s stock tumbles after retailer misses earnings estimates and lowers guidance
Dollar General's stock tanked after quarterly earnings fell short and the retailer lowered its guidance by a wide margin.
Europe Markets: Traders pare back ECB rate hike bets as core eurozone inflation cools
Benchmark European government bond yields fell alongside the euro as traders reduced bets on an imminent interest rate hike by the bloc's central bank after...
: Dollar General’s stock tumbles premarket after earnings miss and lowered guidance
Dollar General Corp.’s stock DG tumbled 13.7% in premarket trade Thursday, after the discount retailer posted weaker-than-expected second-quarter earnings and lowered its guidance. “While we...
: Ciena’s stock surges after profit and revenue rise above projections
Shares of Ciena Corp. CIEN surged 2.0% toward a 2 1/2-month high in premarket trading Thursday, after the optical networking company reported fiscal third-quarter results...
: Campbell Soup stock gains ground after profit matches expectations while sales top, as prices jump 10%
Shares of Campbell Soup Co. CPB tacked on 0.9% in premarket trading Thursday, after the canned soup, foods and snacks company reported fiscal fourth-quarter profit...
: Job-cut announcements triple in August: Challenger
U.S.-based employers announced 75,151 cuts in August, a 217% increase from the 23,697 cuts announced in July, according to Challenger, Gray & Christmas. It is...
: Sage Therapeutics to lay off 40% of staff as it gears up for launch of postpartum-depression treatment
Sage Therapeutics Inc. SAGE said Thursday it is reorganizing its business operations and workforce as it gears up for the launch of its postpartum-depression treatment...
: Crinetics Pharmaceuticals shares rise as analysts see ‘drug hunters in their zone’
Shares of Crinetics Pharmaceuticals Inc. CRNX gained more than 4% premarket on Thursday after Oppenheimer analysts initiated coverage of the shares with an outperform rating,...